Home Finance Actuate Therapeutics CEO Daniel Schmitt purchases $49,999 in stock
Finance

Actuate Therapeutics CEO Daniel Schmitt purchases $49,999 in stock

Share
Actuate Therapeutics CEO Daniel Schmitt purchases ,999 in stock
Share


Actuate Therapeutics CEO Daniel Schmitt purchases $49,999 in stock

Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *